A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gemcitabine/carboplatin|DRUG: iniparib
Sponsor: Sanofi
Collaborators: BiPar Sciences